Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Dentsply Sirona (XRAY) Cost of Revenue (2016 - 2025)

Dentsply Sirona's Cost of Revenue history spans 17 years, with the latest figure at $518.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 12.85% year-over-year to $518.0 million, compared with a TTM value of $1.8 billion through Dec 2025, changed 0.27%, and an annual FY2025 reading of $1.8 billion, changed 0.27% over the prior year.
  • Cost of Revenue for Q4 2025 was $518.0 million at Dentsply Sirona, up from $463.0 million in the prior quarter.
  • The five-year high for Cost of Revenue was $518.0 million in Q4 2025, with the low at $413.0 million in Q1 2025.
  • Average Cost of Revenue over 5 years is $461.6 million, with a median of $459.0 million recorded in 2023.
  • Year-over-year, Cost of Revenue surged 47.32% in 2021 and then decreased 7.61% in 2025.
  • Tracing XRAY's Cost of Revenue over 5 years: stood at $499.0 million in 2021, then decreased by 6.61% to $466.0 million in 2022, then increased by 5.15% to $490.0 million in 2023, then dropped by 6.33% to $459.0 million in 2024, then rose by 12.85% to $518.0 million in 2025.
  • Per Business Quant, the three most recent readings for XRAY's Cost of Revenue are $518.0 million (Q4 2025), $463.0 million (Q3 2025), and $446.0 million (Q2 2025).